AllianceBernstein’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.96M | Hold |
272,523
| – | – | ﹤0.01% | 1483 |
|
|
2025
Q1 | $5.41M | Sell |
272,523
-2,740
| -1% | -$54.4K | ﹤0.01% | 1428 |
|
|
2024
Q4 | $4.72M | Buy |
275,263
+32,923
| +14% | +$565K | ﹤0.01% | 1520 |
|
|
2024
Q3 | $4.84M | Sell |
242,340
-1,130
| -0.5% | -$22.6K | ﹤0.01% | 1525 |
|
|
2024
Q2 | $2.72M | Buy |
243,470
+25,100
| +11% | +$281K | ﹤0.01% | 1781 |
|
|
2024
Q1 | $1.44M | Buy |
218,370
+30,770
| +16% | +$203K | ﹤0.01% | 2083 |
|
|
2023
Q4 | $848K | Hold |
187,600
| – | – | ﹤0.01% | 2354 |
|
|
2023
Q3 | $672K | Hold |
187,600
| – | – | ﹤0.01% | 2421 |
|
|
2023
Q2 | $692K | Buy |
187,600
+76,400
| +69% | +$282K | ﹤0.01% | 2477 |
|
|
2023
Q1 | $368K | Hold |
111,200
| – | – | ﹤0.01% | 2693 |
|
|
2022
Q4 | $431K | Buy |
111,200
+65,200
| +142% | +$253K | ﹤0.01% | 2704 |
|
|
2022
Q3 | $112K | Buy |
46,000
+20,800
| +83% | +$50.6K | ﹤0.01% | 3103 |
|
|
2022
Q2 | $50K | Buy |
+25,200
| New | +$50K | ﹤0.01% | 3169 |
|
|
2021
Q2 | – | Sell |
-82,000
| Closed | -$144K | – | 3309 |
|
|
2021
Q1 | $144K | Sell |
82,000
-700
| -0.8% | -$1.23K | ﹤0.01% | 3102 |
|
|
2020
Q4 | $161K | Sell |
82,700
-25,800
| -24% | -$50.2K | ﹤0.01% | 3031 |
|
|
2020
Q3 | $259K | Sell |
108,500
-76,400
| -41% | -$182K | ﹤0.01% | 2863 |
|
|
2020
Q2 | $542K | Buy |
184,900
+94,400
| +104% | +$277K | ﹤0.01% | 2551 |
|
|
2020
Q1 | $261K | Buy |
90,500
+66,900
| +283% | +$193K | ﹤0.01% | 2679 |
|
|
2019
Q4 | $94K | Hold |
23,600
| – | – | ﹤0.01% | 3037 |
|
|
2019
Q3 | $105K | Hold |
23,600
| – | – | ﹤0.01% | 3063 |
|
|
2019
Q2 | $91K | Buy |
+23,600
| New | +$91K | ﹤0.01% | 3087 |
|